Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $237K | $316K | $225K | $241K |
| Revenue growth | — | — | — | 33.3% | -28.8% | 7.1% |
| Operating income | — | -$5.20M | -$8.71M | -$18.4M | -$19.3M | -$22.3M |
| Operating margin | — | — | -3673.4% | -5809.8% | -8558.2% | -9240.7% |
| Net income | — | -$252K | -$15.9M | -$29.9M | -$20.8M | -$23.8M |
| Net margin | — | — | -6718.6% | -9469.0% | -9242.2% | -9857.3% |
| EPS (diluted) | — | — | -$1.57 | -$2.54 | -$1.49 | -$1.23 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | -$3.24M | -$8.80M | -$17.1M | -$17.9M | -$18.2M |
| Capital expenditures | — | — | $218K | $153K | $980K | $179K |
| Free cash flow | — | — | -$9.02M | -$17.2M | -$18.9M | -$18.4M |
| Dividends paid | — | — | — | — | $2.45M | $1.82M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $25.0K | $1.12M | $183K | $4.22M | $5.48M | $3.74M |
| Total assets | $120K | $427M | $2.56M | $8.27M | $11.5M | $8.56M |
| Total liabilities | $95.7K | $38.6M | $38.8M | $10.0M | $30.4M | $20.3M |
| Shareholders' equity | $24.3K | -$45.0M | -$36.2M | -$1.78M | -$18.8M | -$12.2M |
| Retained earnings | -$701.00 | -$36.7M | -$226M | -$257M | -$285M | -$313M |
| Shares (wtd avg diluted) | — | — | 10.1M | 12.3M | 18.8M | 23.3M |
Every figure is extracted from Envoy Medical, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.